Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
e-therapeutics Announces Business Updates and Interim Results LONDON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to...
AIM 09 May 2024 NOTICE 09/05/2024 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM At the request of the company the following securities have been cancelled from trading...
e-Therapeutics plc 08 May 2024 e-therapeutics plc ("e-therapeutics" or "ETX" or the "Company") Last Day of Dealings on AIM London, UK, 8 May 2024 - e-therapeutics plc (AIM:...
FTSE Russell 03 May 2024 E-therapeutics (UK): Constituent Deletion Changes in FTSE UK Index Series 03 May 2024 Subject to the expected cancellation of trading on AIM for E-therapeutics...
e-Therapeutics plc 29 April 2024 e-therapeutics plc ("e-therapeutics" or "ETX" or the "Company") Result of General Meeting Matched Bargain Settlement Facility London, UK, 29...
e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option ...
e-Therapeutics plc 10 April 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue...
e-Therapeutics plc 31 January 2024 e-therapeutics plc ("e-therapeutics" or the "Company") Total Voting Rights London, UK, 31 January 2024 - e-therapeutics plc (AIM: ETX), a company...
e-Therapeutics plc 24 January 2024 e-therapeutics plc ("e-therapeutics" or the "Company") Exercise of Options and Issue of Equity London, UK, 24 January 2024 - e-therapeutics...
C - Oxford, England-based computer-based drug discovery company - Says 2023 was "a year of significant execution and ...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | DE |
| 4 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | DE |
| 12 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | DE |
| 26 | 0 | 0 | 9 | 9 | 9 | 0 | 0 | DE |
| 52 | -1.65 | -15.4929577465 | 10.65 | 18.5 | 8 | 281182 | 11.32783445 | DE |
| 156 | -37.3 | -80.5615550756 | 46.3 | 48.4 | 8 | 245022 | 18.89156029 | DE |
| 260 | 5.95 | 195.081967213 | 3.05 | 48.4 | 2.95 | 598133 | 17.36529816 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
